Read + Share
Wimbury D, Muto M, Bhachu JS, Scionti K, et al. Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin
A nephropathy: insights from the NEFIGAN trial. Kidney Int 2024;105:381-388.
PMID: 38008160
|
 |
|
Wimbury D, Muto M, Bhachu JS, Scionti K, et al. Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin
A nephropathy: insights from the NEFIGAN trial. Kidney Int 2024;105:381-388.
PMID: 38008160
|
|
|
|